Lv1
40 积分 2023-11-25 加入
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
1天前
待确认
Manufacturing chimeric antigen receptor T cells: issues and challenges
1天前
已完结
Engineered exosome-mediated messenger RNA and single-chain variable fragment delivery for human chimeric antigen receptor T-cell engineering
8天前
已完结
In vivo CAR T cells move into clinical trials
13天前
已完结
In vivo CAR T cells move into clinical trials
13天前
已完结
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
22天前
已完结
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
22天前
已完结
CAR T cell immunotherapy for human cancer
28天前
已完结
In vivo gene immunotherapy for cancer
28天前
已完结
皖公网安备34019202002308
